Trial Profile
An open-label phase II study of navelbine (vinorelbine tartrate) and Taxotere (docetaxel) as first-line therapy for metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Aug 2020
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Vinorelbine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 12 Aug 2020 Status changed from active, no longer recruiting to completed.
- 09 Sep 2005 New trial record.